Skip to content

Evaluation of the Effectiveness of Wearable Device-Assisted Remote Pulmonary Rehabilitation in Patients with F-ILD: A Randomized Controlled Trial

Evaluation of the Effectiveness of Wearable Device-Assisted Remote Pulmonary Rehabilitation in Patients with F-ILD: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126422
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrotic Interstitial Lung Disease

Interventions

Remote Home Pulmonary Rehabilitation Group:Exercise training (breathing exercises, aerobic exercise, resistance training, flexibility training), education, nutritional support, and psychological and b
Usual Care Group:Receives standard medical management and routine health education, but does not receive structured remote rehabilitation training.

Sponsors

General Hospital of Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Definite diagnosis of F-ILD (e.g, IPF, connective tissue disease-associated F-ILD, fibrotic hypersensitivity pneumonitis, idiopathic non-specific interstitial pneumonia, unclassifiable idiopathic interstitial pneumonia, environmental/occupational lung disease, or sarcoidosis) confirmed by multidisciplinary discussion (MDT) involving pulmonologist, radiologist, pathologist, and rheumatologist, with evidence of F-ILD on high-resolution CT; 2.Clinically stable, receiving treatment with antifibrotic agents, and no acute exacerbation within the past 4 weeks; 3.Patients with F-ILD who are able to walk independently; 4.Male or female patients aged 30–75 years; 5.Patients with F-ILD who have resting oxygen saturation >=90%; 6.Patients capable of verbal or written communication and able to complete protocol-related auxiliary examinations; 7.The patient or their family member is able to use a smartphone and can interact well with the physician via the phone; 8.Written informed consent obtained from the patient after approval by the ethics committee.

Exclusion criteria

Exclusion criteria: 1.Recent myocardial infarction; presence of unstable angina, acute pulmonary edema, acute myocarditis or pericarditis; severe arrhythmias, bedridden rheumatic disease, severe pulmonary arterial hypertension (PAH); 2.Acute exacerbation of F-ILD; 3.Patients with dyspnea corresponding to an mMRC score of 4; 4.Unable to walk; 5.Concurrent hematologic diseases or malignant tumors that may affect study completion; 6.Severe cognitive impairment preventing the patient from following written and verbal commands; 7.Patient or family members unwilling to participate; 8.Patients with musculoskeletal or neurological diseases that prevent mobility or the ability to perform mild exercise; 9.Currently participating in or having participated in any form of pulmonary rehabilitation within the last 6 months.

Design outcomes

Primary

MeasureTime frame
6 minutes walking distance varies, 6MWT;

Secondary

MeasureTime frame
1 minute sitting and standing test, 1-min STST;Lung function;Respiratory muscle strength;Shortness of breath symptoms (mMRC);Fatigue Score (FAS);Quality of Life (KBILD);Psychological status (HADs);Sarcopenia Scale (SARC-F) score;Grip strength;Calf circumference;Skeletal muscle mass index;Acute exacerbation;Readmission rate;

Countries

China

Contacts

Public ContactJuan Chen

General Hospital of Ningxia Medical University

Chenjuan7419@163.com+86 130 1429 2231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026